Janus Henderson Investors US’s Ascendis Pharma A/S ASND Stock Holding History

Janus Henderson Investors US’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$15.7M	Sell	559,035 -35,260	-6%	-$891K	0.01%	646
2016 Q4	$12M	Sell	594,295 -53,702	-8%	-$1.07M	0.01%	700
2016 Q3	$13M	Sell	647,997 -14,897	-2%	-$246K	0.01%	662
2016 Q2	$8.8M	Sell	662,894 -7,113	-1%	-$110K	0.01%	686
2016 Q1	$12.4M	Sell	670,007 -31,909	-5%	-$567K	0.01%	637
2015 Q4	$12.9M	Sell	701,916 -12,847	-2%	-$225K	0.01%	671
2015 Q3	$12.7M	Buy	+714,763	New	+$13.9M	0.01%	682

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Janus Henderson Investors US's ASND Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Ascendis Pharma A/S (ASND) stake by 5.9% in Q1 2017, selling an estimated $891K and leaving 559,035 shares worth $15.7M. The position accounts for 0.01% of the portfolio, ranked #646.

Janus Henderson Investors US first reported a position in ASND in Q3 2015 and has held it in 7 quarters since. 35 funds tracked by Wall St. Rank hold ASND as of Q1 2017.

Janus Henderson Investors US held 559,035 shares of Ascendis Pharma A/S worth $15.7M as of Q1 2017.
Janus Henderson Investors US sold 35,260 Ascendis Pharma A/S shares in Q1 2017, an estimated $891K.
Ascendis Pharma A/S made up 0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #646 holding.
Janus Henderson Investors US first reported a position in Ascendis Pharma A/S in Q3 2015 and has held it in 7 quarters since.
35 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.